Stool Softener

DOCUSATE SODIUM ORAL HUMAN OTC DRUG

Stool Softener is an FDA drug label for the active ingredient DOCUSATE SODIUM manufactured by Geri-Care Pharmaceutical Corp administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231115.

Generic name
DOCUSATE SODIUM
Manufacturer
Geri-Care Pharmaceutical Corp
Product type
HUMAN OTC DRUG
Route
ORAL
Dosage form
N/A
NDC
57896-426
Application
M007
Label effective
20231115

Active ingredients

Active ingredient (in each softgel) Docusate Sodium 250 mg

Indications & Usage

Uses relieves occasional constipation (irregularity) generally produces bowel movement in 12 to 72 hours

Dosage & Administration

Directions adults and children 12 years and older: take 1 softgel daily or as directed by a doctor children under 12: do not use do not exceed recommended dose

Contraindications

Not available.

Warnings

Warnings Ask a doctor before use if you have stomach pain, nausea, or vomiting have a sudden change in bowel habits that persists over a period of 2 weeks are presently taking mineral oil Stop use and ask a doctor if you need to use a laxative longer than 1 week you have rectal bleeding or fail to have a bowel movement. These could be signs of a serious condition. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose , get medical help or contact a Poison Control Center right away.

Adverse Reactions

Not available.

More products with the same ingredient

DOCUSATE SODIUM

DOK

MAJOR PHARMACEUTICALS View label

Docusate Sodium

A-S Medication Solutions View label

Docusate Sodium

Asclemed USA, Inc. View label